Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions. LICENSE, DEVELOPMENT and COOPERATION AGREEMENT VILAZODONE (EMD 68843) by and between: Merck KGaA and: Genaissance...Registration Rights Agreement • October 13th, 2004 • Genaissance Pharmaceuticals Inc • Services-commercial physical & biological research
Whereas, MERCK KGAA and GlaxoSmithKline (GSK) have carried out extensive preclinical research and development work and certain clinical studies on VILAZODONE defined below.
